Hyundai ADM Bio (KOSDAQ:187660) Has Debt But No Earnings; Should You Worry?
Dec 19
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Life Sciences Industry Analysis
UpdatedDec 20, 2024
DataAggregated Company Financials
Companies30
- 7D-0.9%
- 3M-8.7%
- 1Y36.8%
- YTD22.5%
The Life Sciences industry is up 3.2% in the last week, with ENCell up 6.5%. During this same period, the LigaChem Biosciences underperformed, falling 12%. In the last 12 months, the industry was up 39%. Looking forward, earnings are forecast to grow by 19% annually.
Industry Valuation and Performance
Has the South Korean Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 20 Dec 2024 | ₩75.9t | ₩5.0t | ₩965.6b | 13x | 78.6x | 15.2x |
| Sun, 17 Nov 2024 | ₩76.0t | ₩4.8t | ₩885.3b | 12.5x | 85.8x | 15.7x |
| Tue, 15 Oct 2024 | ₩81.7t | ₩4.8t | ₩885.3b | 14x | 92.3x | 16.8x |
| Thu, 12 Sep 2024 | ₩76.5t | ₩4.8t | ₩885.3b | 13.6x | 86.4x | 15.8x |
| Sat, 10 Aug 2024 | ₩75.2t | ₩4.5t | ₩731.7b | 15.3x | 102.8x | 16.6x |
| Mon, 08 Jul 2024 | ₩63.8t | ₩4.5t | ₩731.7b | 18.6x | 87.2x | 14.1x |
| Wed, 05 Jun 2024 | ₩59.4t | ₩4.6t | ₩696.4b | 20x | 85.3x | 12.8x |
| Fri, 03 May 2024 | ₩61.0t | ₩4.4t | ₩635.1b | 18.9x | 96x | 13.9x |
| Sun, 31 Mar 2024 | ₩66.2t | ₩4.7t | ₩656.9b | 19.3x | 100.8x | 14.2x |
| Tue, 27 Feb 2024 | ₩63.7t | ₩4.5t | ₩714.4b | 34.6x | 89.1x | 14.1x |
| Thu, 25 Jan 2024 | ₩61.8t | ₩4.5t | ₩714.4b | 34.1x | 86.5x | 13.7x |
| Sat, 23 Dec 2023 | ₩57.1t | ₩4.5t | ₩721.5b | 30.9x | 79.2x | 12.6x |
| Mon, 20 Nov 2023 | ₩56.9t | ₩4.4t | ₩651.1b | 23.5x | 87.4x | 12.9x |
| Wed, 18 Oct 2023 | ₩57.0t | ₩4.4t | ₩660.9b | 37.5x | 86.2x | 13x |
| Fri, 15 Sep 2023 | ₩58.3t | ₩4.4t | ₩660.9b | 28.2x | 88.3x | 13.3x |
| Sun, 13 Aug 2023 | ₩63.0t | ₩4.2t | ₩673.4b | 29x | 93.6x | 15x |
| Tue, 11 Jul 2023 | ₩55.3t | ₩4.2t | ₩673.4b | 28.9x | 82.1x | 13.2x |
| Thu, 08 Jun 2023 | ₩61.2t | ₩4.2t | ₩666.5b | 31.7x | 91.9x | 14.4x |
| Sat, 06 May 2023 | ₩62.4t | ₩4.1t | ₩626.3b | 28x | 99.6x | 15.3x |
| Mon, 03 Apr 2023 | ₩61.2t | ₩4.1t | ₩626.3b | 28.5x | 97.8x | 15x |
| Wed, 01 Mar 2023 | ₩60.4t | ₩3.5t | ₩427.8b | 21x | 141.3x | 17.3x |
| Fri, 27 Jan 2023 | ₩62.1t | ₩3.5t | ₩426.6b | 20.5x | 145.5x | 17.8x |
| Sun, 25 Dec 2022 | ₩63.0t | ₩3.4t | ₩428.7b | 21.3x | 146.9x | 18.3x |
| Tue, 22 Nov 2022 | ₩68.9t | ₩3.4t | ₩440.9b | 22.9x | 156.2x | 20.3x |
| Thu, 20 Oct 2022 | ₩65.7t | ₩3.0t | ₩448.5b | 23.4x | 146.4x | 22x |
| Sat, 17 Sep 2022 | ₩63.0t | ₩3.0t | ₩448.5b | 28.5x | 140.4x | 21.1x |
| Mon, 15 Aug 2022 | ₩71.9t | ₩2.7t | ₩454.7b | 28.3x | 158.2x | 26.5x |
| Wed, 13 Jul 2022 | ₩66.1t | ₩2.7t | ₩454.7b | 27.1x | 145.4x | 24.4x |
| Fri, 10 Jun 2022 | ₩66.5t | ₩2.7t | ₩454.1b | 27x | 146.5x | 24.6x |
| Sun, 08 May 2022 | ₩63.0t | ₩2.4t | ₩379.4b | 23.1x | 166x | 26x |
| Tue, 05 Apr 2022 | ₩60.8t | ₩2.4t | ₩379.4b | 25.6x | 160.2x | 25.1x |
| Thu, 03 Mar 2022 | ₩57.4t | ₩2.4t | ₩409.6b | 25.4x | 140.1x | 24.4x |
| Sat, 29 Jan 2022 | ₩55.6t | ₩2.3t | ₩412.7b | 23.7x | 134.7x | 23.7x |
| Mon, 27 Dec 2021 | ₩66.5t | ₩2.3t | ₩412.7b | 28.8x | 161.2x | 28.3x |
Price to Earnings Ratio
161.2x
Current Industry PE
- Investors are pessimistic on the South Korean Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 78.4x which is lower than its 3-year average PE of 114x.
- The industry is trading close to its 3-year average PS ratio of 17.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have grown 34% per year over the last three years.
- Revenues for these companies have grown 26% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | -1.64% | |
| Healthcare | 0.13% | |
| Life Sciences | -0.89% | |
| Clinical Research and Equipment | -0.89% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A456070 ENCell | ₩15.93k | 6.5% +₩10.4b | n/a | n/a | |
| A238120 Aligned Genetics | ₩3.12k | 4.5% +₩1.9b | -19.6% | PE18.1x | |
| A347740 P&K Skin Research Center | ₩2.16k | 2.9% +₩1.7b | -13.9% | PE9.2x | |
| A246250 SLS BIO | ₩2.08k | 5.7% +₩1.5b | -22.8% | n/a | |
| A038290 Macrogen | ₩16.55k | 0.9% +₩1.5b | -18.3% | PS1.3x |
